Director, HEOR Oncology US Medical Affairs in Basking Ridge, NJ at DSI

Date Posted: 1/8/2022

Job Snapshot

Job Description

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

This individual will play a strategic role in leading the design and implementation of health economics and outcomes research strategy to ensure optimal market access and appropriate utilization for Daiichi Sankyo products in the US.  He/She will drive asset specific US HEOR strategy and coordinate the corresponding HEOR and RWE activities in collaboration with cross-functional teams. The role will be responsible for the implementation of HEOR tactics, which may include health economic models, real-world evidence studies, patient reported outcomes analysis, innovative tools, methods, and strategies to ensure successful market access and support the company's vision of being a leader in oncology and deliver innovative treatments to patients
  • Establish Daiichi Sankyo as a preferred research partner for academic thought leaders, co-development/promotion partners and strategic managed markets customers by facilitating the acquisition of corporate expertise in Health Economics & Outcomes Research (HEOR). Serve as a core member of cross-function product brand teams and medical teams to ensure successful creation and implementation of optimal market access, HEOR strategies and tactics.   Serve as an expert to inform Clinical Development, Medical Affairs, Global HEOR and other DSI colleagues on market trends in the regulations, utilization and importance of HEOR evidence for the US market.   
  • Partner with cross-functional teams and external research organizations to develop Health Economics and Outcomes Research strategies and real-world evidence tactics that support successful commercialization of DSI products in the US.  Partner with colleagues in global functions, US Marketing and Managed Markets to contribute HEOR expertise in the development of marketing, pricing and reimbursement strategies and policies.  Provide input to clinical development and commercial planning activities. 
  • Lead the implementation of US HEOR and real-world evidence tactics, development of formulary dossiers, interactive health economic and budget impact modeling tools, journal publications, conference abstracts/posters/slide sets, and direct to consumer and physician campaigns and detail aids. Assist in the design and implementation of processes to increase research efficiency and effectiveness in the dissemination of HEOR messages in scientific exchange, brand promotion and commercial payer education activities.  Establish a strong collaboration with external research partners and thought leaders to benchmark the success of Daiichi Sankyo against competitive companies’ HEOR functions in order to ensure “Best in Class” performance.  
  • Contribute to Patient Reported Outcomes and Economic endpoints strategy for clinical trials.  Where appropriate, lead project teams responsibility for the development and validation of new PRO instruments. Partner with Patient Advocacy Organizations to design research projects to improve the quality of care and quality of life of patients and their caregivers.  
  • Develop HEOR materials to support external communications with health care stakeholders.  Accompany Field Medical Liaisons as necessary during strategic account presentations and/or attend research planning meetings to discuss health outcome research design and methodology issues and/or review product health outcomes data.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university)
  • Doctoral or Master degree in Health Economics, Pharmacy Administration, Biostatistics, Health Services Research, Epidemiology, Health Policy, Outcomes Research or similar discipline; M.D. with additional training in Health Economics/Outcomes Research; Pharm.D. with addition training in Health Economics/Outcomes Research fellowship.
Experience Qualifications
  • Minimum 10 years of experience in pharmaceutical or healthcare industry, 8 of which must be working in the HEOR field; Relevant experience in contract research organization and academic setting may be considered.
  • Track record of peer-reviewed publications is required.   
  • Previous experience in oncology preferred.
  • Previous experience in interacting with HTA agencies and US payer groups is a positive consideration.
  • Previous experience in economic modeling, econometrics and/or retrospective database analysis is a positive consideration.
  • Previous experience in clinical research, pharmaceutical marketing or market research is a positive consideration.
Role requires up to 30% travel

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.